Mark Schmidt to Cohort Studies
This is a "connection" page, showing publications Mark Schmidt has written about Cohort Studies.
Connection Strength
0.589
-
Herpes zoster diagnosis and treatment in relation to incident dementia: A population-based retrospective matched cohort study. PLoS One. 2024; 19(1):e0296957.
Score: 0.148
-
Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine. Vaccine. 2010 Nov 16; 28(49):7713-5.
Score: 0.059
-
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis?C and Cirrhosis. Adv Ther. 2024 Feb; 41(2):744-758.
Score: 0.037
-
Persistent pruritus associated with worse quality of life in patients with chronic hepatitis. Liver Int. 2024 Feb; 44(2):577-588.
Score: 0.037
-
Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat. 2023 09; 30(9):746-755.
Score: 0.036
-
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States. J Viral Hepat. 2023 06; 30(6):512-519.
Score: 0.035
-
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Aliment Pharmacol Ther. 2019 03; 49(5):599-608.
Score: 0.026
-
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings. Infect Dis Clin North Am. 2018 06; 32(2):253-268.
Score: 0.025
-
Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017 Jun; 32(6):1250-1257.
Score: 0.023
-
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study. Dig Dis Sci. 2016 12; 61(12):3469-3477.
Score: 0.022
-
Infrequent Clinical Assessment of Chronic Hepatitis B Patients in United States General Healthcare Settings. Clin Infect Dis. 2016 11 01; 63(9):1205-1208.
Score: 0.022
-
All-Cause Mortality and Progression Risks to Hepatic Decompensation and Hepatocellular Carcinoma in Patients Infected With Hepatitis C Virus. Clin Infect Dis. 2016 Feb 01; 62(3):289-297.
Score: 0.021
-
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention. Hepatology. 2015 May; 61(5):1479-84.
Score: 0.020
-
Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology. 2015 Mar; 61(3):802-11.
Score: 0.020
-
Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohort. Clin Infect Dis. 2015 Feb 15; 60(4):514-22.
Score: 0.020
-
APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014 Dec; 21(12):917-20.
Score: 0.019
-
Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identification. Dig Dis Sci. 2014 Dec; 59(12):3053-61.
Score: 0.019